Masimo is a medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation solutions. Co.'s main business is Measure-through Motion and Low Perfusion pulse oximetry. Co.'s products offerings also include noninvasive monitoring of blood constituents with an optical signature, optical oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring, exhaled gas monitoring, nasal high flow ventilation, minimally invasive neuromodulation technology for pain and addiction reduction, hospital automation and connectivity solutions and home wellness and monitoring. When considering the Masimo Corp. stock dividend history, we have taken known splits into account, such that the MASI dividend history is presented on a split-adjusted ("apples to apples") basis. Masimo Corp. dividend history is presented both in graphical/chart form, and as a MASI dividend history data table along the right-hand column.
|
MASI Stock Dividend HistoryThe MASI dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable MASI historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the MASI dividend history record. Also see the MASI stock dividend history data table along the right-hand column below. |
|
|
Buy (2.86 out of 4) 26th percentile
(ranked lower than approx. 74% of all stocks covered)
Analysts' Target Price: MASI Forecast Based on data provided by Zacks Investment Research via Quandl.com |